Consistently, by introducing mutant amyloid precursor protein (APP) into the APOE ε4-induced brain organoid, we were able to faithfully recapitulate the acceleration of AD-related pathologies, suggesting that this model provides a physiologically relevant and patient-specific representation of AD. This evidence concerns the gene APOE and Alzheimer disease.